New Funding for Diabetes & Cardiovascular Disease on Offer Through the TTRA Initiative

The Targeted Translation Research Accelerator (TTRA) initiative for diabetes and cardiovascular disease, supported by the Medical Research Future Fund, is providing a new integrated research program to improve the prevention, diagnosis, treatment and management of diabetes and cardiovascular disease (D&CVD) in Australia. The TTRA is calling for Expressions of Interest (EOI) for the second round of the Research Projects opportunity to fund eligible organisations in developing innovative digital health solutions, medical devices, therapeutics and behavioural interventions for D&CVD. This Information Session webinar provides valuable information about the funding application process, priority research areas & includes a Question & Answer segment. Applications close 25 November 2021 (deadline extended)! 

Hear from MTPConnect’s team:

Managing Director & CEO - Dr Dan Grant, Senior Director TTRA Program - Lauren Kelly, Director TTRA Program - Dr Mana Liao and Project Manager TTRA Program - Dr Erin McAllum.

You will also hear from our TTRA program partners who will provide mentoring and commercialisation advice to applicants and those receiving funding:

ANDHealth's Chief Product Officer & Co-Founder - Grace Lethlean, MDPP's National Program Manager - Olivia White and UniQuest's Project Manager, TTRA Program - Dr Leigh Ford.